Drug Pipeline

Daunorubicin or Idarubicin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07223814 Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by… Acute Myeloid Leukemia Recruiting
Phase 2
NCT03591510 A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety… FLT3-mutated Acute Myeloid Leukemia Active, Not Recruiting
Phase 1
NCT05453903 A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies Leukemia, Myeloid, Acute Active, Not Recruiting
Sponsors Running Daunorubicin or Idarubicin Trials
Novartis Pharmaceuticals (1) Janssen Research & Development, LLC (1) Stichting Hemato-Oncologie voor Volwassenen Nederland (1)
Disease Areas
Leukemia (3) Acute Myeloid Leukemia (AML) (2)
Get alerts when Daunorubicin or Idarubicin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free